Stewart CF - Search Results

1

Phase I study of vandetanib during and after radiotherapy in children with diffuse intrinsic pontine glioma.

Broniscer A, Baker JN, Tagen M, Onar-Thomas A, Gilbertson RJ, Davidoff AM, Pai Panandiker AS, Leung W, Chin TK, Stewart CF, Kocak M, Rowland C, Merchant TE, Kaste SC, Gajjar A. Broniscer A, et al. Among authors: stewart cf. J Clin Oncol. 2010 Nov 1;28(31):4762-8. doi: 10.1200/JCO.2010.30.3545. Epub 2010 Oct 4. J Clin Oncol. 2010. PMID: 20921456 Free PMC article. Clinical Trial.

2

Clinical pharmacodynamics of continuous infusion topotecan in children: systemic exposure predicts hematologic toxicity.

Stewart CF, Baker SD, Heideman RL, Jones D, Crom WR, Pratt CB. Stewart CF, et al. J Clin Oncol. 1994 Sep;12(9):1946-54. doi: 10.1200/JCO.1994.12.9.1946. J Clin Oncol. 1994. PMID: 8083716 Clinical Trial.

3

Phase I study of topotecan for pediatric patients with malignant solid tumors.

Pratt CB, Stewart C, Santana VM, Bowman L, Furman W, Ochs J, Marina N, Kuttesch JF, Heideman R, Sandlund JT, et al. Pratt CB, et al. J Clin Oncol. 1994 Mar;12(3):539-43. doi: 10.1200/JCO.1994.12.3.539. J Clin Oncol. 1994. PMID: 8120551 Clinical Trial.

4

Cerebrospinal fluid pharmacokinetics and penetration of continuous infusion topotecan in children with central nervous system tumors.

Baker SD, Heideman RL, Crom WR, Kuttesch JF, Gajjar A, Stewart CF. Baker SD, et al. Among authors: stewart cf. Cancer Chemother Pharmacol. 1996;37(3):195-202. doi: 10.1007/BF00688317. Cancer Chemother Pharmacol. 1996. PMID: 8529278

5

Escalating systemic exposure of continuous infusion topotecan in children with recurrent acute leukemia.

Furman WL, Baker SD, Pratt CB, Rivera GK, Evans WE, Stewart CF. Furman WL, et al. Among authors: stewart cf. J Clin Oncol. 1996 May;14(5):1504-11. doi: 10.1200/JCO.1996.14.5.1504. J Clin Oncol. 1996. PMID: 8622064 Clinical Trial.

6

Topoisomerase I interactive drugs in children with cancer.

Stewart CF, Zamboni WC, Crom WR, Gajjar A, Heideman RL, Furman WL, Meyer WH, Houghton PJ, Pratt CB. Stewart CF, et al. Invest New Drugs. 1996;14(1):37-47. doi: 10.1007/BF00173681. Invest New Drugs. 1996. PMID: 8880392 Review.

7

Phase I study of topotecan in combination with cyclophosphamide in pediatric patients with malignant solid tumors: a Pediatric Oncology Group Study.

Saylors RL 3rd, Stewart CF, Zamboni WC, Wall DA, Bell B, Stine KC, Vietti TJ. Saylors RL 3rd, et al. Among authors: stewart cf. J Clin Oncol. 1998 Mar;16(3):945-52. doi: 10.1200/JCO.1998.16.3.945. J Clin Oncol. 1998. PMID: 9508177 Clinical Trial.

8

Phenytoin alters the disposition of topotecan and N-desmethyl topotecan in a patient with medulloblastoma.

Zamboni WC, Gajjar AJ, Heideman RL, Beijnen JH, Rosing H, Houghton PJ, Stewart CF. Zamboni WC, et al. Among authors: stewart cf. Clin Cancer Res. 1998 Mar;4(3):783-9. Clin Cancer Res. 1998. PMID: 9533548

9

Phase I study of DMP 840 in pediatric patients with refractory solid tumors.

Thompson J, Pratt CB, Stewart CF, Avery L, Bowman L, Zamboni WC, Pappo A. Thompson J, et al. Among authors: stewart cf. Invest New Drugs. 1998;16(1):45-9. doi: 10.1023/a:1006014510078. Invest New Drugs. 1998. PMID: 9740543 Clinical Trial.

10

A four-hour topotecan infusion achieves cytotoxic exposure throughout the neuraxis in the nonhuman primate model: implications for treatment of children with metastatic medulloblastoma.

Zamboni WC, Gajjar AJ, Mandrell TD, Einhaus SL, Danks MK, Rogers WP, Heideman RL, Houghton PJ, Stewart CF. Zamboni WC, et al. Among authors: stewart cf. Clin Cancer Res. 1998 Oct;4(10):2537-44. Clin Cancer Res. 1998. PMID: 9796988

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

325 results

Search Page

Filters